Diabetes decisions — 2024

The Veteran's service-connected disabilities, including PTSD, right shoulder disorder, OSA, and diabetes mellitus, rendered him unable to secure or follow a substantially gainful occupation from August 9, 2019, to May 6, 2021. Therefore, the Board granted his claim for TDIU during this period.

The appeal regarding hypertension is dismissed, and the issue of an increased rating for left upper extremity diabetic peripheral neuropathy is remanded.

The Board has dismissed the appeals for service connection of diabetes mellitus, type II and residuals of gall bladder removal as they are not valid claims.

The Veteran's service-connected disabilities, including bilateral lower extremity sciatic peripheral neuropathy, PTSD, diabetes mellitus, and bilateral hearing loss, prevent him from securing and following substantially gainful employment. The Board has granted a TDIU based on these conditions.

The Veteran's service-connected disabilities, including hemiparesis of the right upper extremity and right lower extremity, unspecified depressive disorder, diabetes mellitus type II with erectile dysfunction, peripheral neuropathy left lower extremity, tinnitus, and hypertension, have rendered him in need of regular aid and attendance. The Board has granted SMC based on this need.

The Veteran's appeals for service connection for diabetes mellitus, special monthly compensation (SMC) based on aid and attendance and/or housebound, obstructive sleep apnea, and fibromyalgia have been dismissed as the claims are still pending in the legacy appeal system.

The Board has remanded the claims of service connection for diabetes mellitus and psoriasis due to a pre-decisional duty to assist error. The Veteran was exposed to herbicide agents during his military service, but VA examinations are needed to determine if these conditions are related to his active service.

The Board has decided to remand the case due to insufficient evidence regarding the cause of death and potential secondary service connection for herbicide-related disorders. The Veteran's cause of death is being reviewed, along with any possible secondary effects from his nonservice-connected conditions.

The Board denied service connection for heart conditions, cirrhosis of the liver, and diabetes. The Veteran's heart disabilities were not related to his active duty in Korea.,The Board also denied service connection for left foot peripheral neuropathy and left ankle condition.

The Board has remanded the claims for hypertension and diabetes mellitus due to insufficient verification of the Veteran's service periods and inadequate VA medical opinions.

The Board denied service connection for ischemic heart disease, diabetes mellitus type II (DMII), cataracts, bilateral upper and lower extremity peripheral neuropathy due to DMII, all based on lack of exposure to herbicide agents during service.,Service connection was not granted as the Veteran's conditions did not have their onset in service or within one year of service.

The Board has remanded the claims for diabetes mellitus, peripheral neuropathy of the right and left lower extremities, and an eye disability due to incomplete development in previous examinations.

The Veteran's right and left upper extremity diabetic peripheral neuropathy are granted with ratings of 40% each, effective September 12, 2023. The Veteran's right and left lower extremity diabetic peripheral neuropathy are also granted with ratings of 40%, effective September 12, 2023.

The Veteran's diabetes mellitus, type II, requires insulin and a restricted diet but not regulation of activities. The Board denied the claim for a disability rating greater than 20 percent.

The Board denied service connection for diabetes mellitus, type II and bilateral cataracts as they are not related to the Veteran's active service.,Service connection was also denied because there is no evidence that the conditions were proximately due or aggravated by a service-connected condition.

The Veteran's claims for earlier effective dates for his awards of service connection for pancreatitis, diabetes mellitus type II with erectile dysfunction, and diabetic peripheral neuropathy of the bilateral upper and lower extremities have been denied. The effective date remains December 12, 2014.

The Board has granted effective dates of May 7, 2021 for both TDIU and DEA benefits based on the Veteran's service-connected disabilities.

Your initial rating for type 2 diabetes mellitus has been set at 20 percent. Your appeal to increase this rating is dismissed.

The Veteran's right and left lower extremity diabetic peripheral neuropathy are granted with a 20% rating, effective August 23, 2023. The claim for service connection of the left upper extremity disability is remanded.

The Veteran's appeal for an earlier effective date for service connection of diabetic peripheral neuropathy of the bilateral lower extremities was dismissed because it is a duplicate appeal that has already been fully adjudicated.